Literature DB >> 10547272

GM-CSF rescues TF-1 cells from growth factor withdrawal-induced, but not differentiation-induced apoptosis: the role of BCL-2 and MCL-1.

L Klampfer1, J Zhang, S D Nimer.   

Abstract

Cytokines such as granulocyte-macrophage colony-stimulating factor (GM-CSF) and IL-3 promote the survival and stimulate the proliferation of haematopoietic cells. Using the GM-CSF-dependent TF-1 myeloid leukaemia cell line, the authors show that the endogenous levels of BCL-2 and MCL-1 are downregulated upon GM-CSF withdrawal, whereas the levels of BCL-x(L)and Bax are unchanged. Re-exposure of growth factor deprived cells to GM-CSF resulted in an early and transient increase in MCL-1 expression, and prolonged induction of BCL-2, which prevented apoptosis. In contrast, the expression of BCL-2 and MCL-1 were not modulated during TPA-induced differentiation of TF-1 cells, which was followed by apoptosis despite the presence of GM-CSF. TF-1 cells overexpressing BCL-2 or MCL-1 underwent delayed apoptosis upon growth factor withdrawal, but displayed no impaired apoptosis in response to TPA. Erythropoietin (Epo) induced the expression of BCL-2 and MCL-1 protein in TF-1 cells, however it did not support their long term proliferation, further demonstrating that upregulation of these anti-apoptotic genes is insufficient for the long term proliferation of TF-1 cells. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10547272     DOI: 10.1006/cyto.1999.0514

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  8 in total

Review 1.  Crossing paths: interactions between the cell death machinery and growth factor survival signals.

Authors:  Gabriela Brumatti; Marika Salmanidis; Paul G Ekert
Journal:  Cell Mol Life Sci       Date:  2010-02-16       Impact factor: 9.261

2.  Homologous Quorum Sensing Regulatory Circuit: A Dual-Input Genetic Controller for Modulating Quorum Sensing-Mediated Protein Expression in E. coli.

Authors:  Pricila Hauk; Kristina Stephens; Chelsea Virgile; Eric VanArsdale; Alex Eli Pottash; John S Schardt; Steven M Jay; Herman O Sintim; William E Bentley
Journal:  ACS Synth Biol       Date:  2020-09-15       Impact factor: 5.110

3.  The GPI-anchored protein CD109 protects hematopoietic progenitor cells from undergoing erythroid differentiation induced by TGF-β.

Authors:  Mikoto Tanabe; Kohei Hosokawa; Mai Anh Thi Nguyen; Noriharu Nakagawa; Kana Maruyama; Noriaki Tsuji; Ryota Urushihara; Luis Espinoza; Mahmoud I Elbadry; Md Mohiuddin; Takamasa Katagiri; Masanori Ono; Hiroshi Fujiwara; Kazuhisa Chonabayashi; Yoshinori Yoshida; Hirohito Yamazaki; Atsushi Hirao; Shinji Nakao
Journal:  Leukemia       Date:  2021-11-06       Impact factor: 11.528

4.  A novel anti-c-Kit antibody-drug conjugate to treat wild-type and activating-mutant c-Kit-positive tumors.

Authors:  Jin-Ock Kim; Kwang-Hyeok Kim; Eun Ji Baek; Bomi Park; Min Kyung So; Byoung Joon Ko; Han-Jik Ko; Sang Gyu Park
Journal:  Mol Oncol       Date:  2021-08-29       Impact factor: 6.603

5.  Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor.

Authors:  Michael Brines; Giovanni Grasso; Fabio Fiordaliso; Alessandra Sfacteria; Pietro Ghezzi; Maddalena Fratelli; Roberto Latini; Qiao-Wen Xie; John Smart; Chiao-Ju Su-Rick; Eileen Pobre; Deborah Diaz; Daniel Gomez; Carla Hand; Thomas Coleman; Anthony Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-29       Impact factor: 11.205

6.  A vaccine strategy with multiple prostatic acid phosphatase-fused cytokines for prostate cancer treatment.

Authors:  Kei Fujio; Masami Watanabe; Hideo Ueki; Shun-Ai Li; Rie Kinoshita; Kazuhiko Ochiai; Junichiro Futami; Toyohiko Watanabe; Yasutomo Nasu; Hiromi Kumon
Journal:  Oncol Rep       Date:  2015-01-29       Impact factor: 3.906

7.  Stable incorporation of GM-CSF into dissolvable microneedle patch improves skin vaccination against influenza.

Authors:  Elizabeth Q Littauer; Lisa K Mills; Nicole Brock; E Stein Esser; Andrey Romanyuk; Joanna A Pulit-Penaloza; Elena V Vassilieva; Jacob T Beaver; Olivia Antao; Florian Krammer; Richard W Compans; Mark R Prausnitz; Ioanna Skountzou
Journal:  J Control Release       Date:  2018-02-26       Impact factor: 9.776

8.  The anticancer drug mithramycin A sensitises tumour cells to apoptosis induced by tumour necrosis factor (TNF).

Authors:  V Duverger; A-M Murphy; D Sheehan; K England; T G Cotter; I Hayes; F J Murphy
Journal:  Br J Cancer       Date:  2004-05-17       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.